EQT AB agreed to buy U.K. veterinary drugmaker Dechra Pharmaceuticals Plc for a lowered price of £4.46 billion (about $5.6 billion) in what is still the biggest European take-private this year.
To read the entire story, you must be logged in.
Please log in now or register with us.
